Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial
Christopher Paul Cannon, Bertrand Cariou, Dirk Jacobus Blom, James M. McKenney, Christelle Lorenzato, Robert C. Pordy, Umesh Chaudhari, Helen Martina Colhoun
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1093/eurheartj/ehv028
- Published
- Feb 16, 2015
- Venue
- European Heart Journal
- DOI
- 10.1093/eurheartj/ehv028
- PubMed
- 25687353
- Categories
- Lipoproteins and Cardiovascular Health
- License
- cc-by-nc
- Provenance
- openalex